BioSpace News Archive

DermaSensor Inc., a health technology company equipping physicians with a non-invasive device for use in the evaluation of suspicious skin lesions, announces the publication of strong results from a multi-center, prospective device validation study for melanoma detection.

ViiV Healthcare today announced the presentation of 64 abstracts that includes highlights of the company’s next-generation pipeline advancements, alongside data from its diverse portfolio of marketed HIV treatment and prevention options at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) being held in Denver, Colorado, from 3 – 6 March 2024.

Empatica, a leader in remote health monitoring powered by AI, is proud to announce the official launch of EpiMonitor, the latest advancement in wearable epilepsy monitoring.

Koning Health, a pioneering medical imaging company, is thrilled to announce that it has received regulatory clearance from the Federal Authority for Nuclear Regulation in the United Arab Emirates, marking a significant milestone in the company’s expansion and its commitment to global health innovation.

Sana Biotechnology, Inc., a company focused on changing the possible for patients through engineered cells, announced that it will webcast its presentation at the Cowen 44th Annual Health Care Conference at 2:50 p.m. ET on Wednesday, March 6, 2024.

Adverum Biotechnologies, Inc. announced that Laurent Fischer, M.D., president and chief executive officer of Adverum Biotechnologies, will participate in the Ophthalmology Corporate Panel Discussion at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5th, 2024 at 9:10 a.m. ET.

Atea Pharmaceuticals, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023 and provided a business update.

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, reported financial results for the three months and full year ended December 31, 2023.

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2023.

Celldex Therapeutics, Inc. announced that it is proposing to offer and sell, subject to market conditions, $250.0 million of shares of its common stock in an underwritten public offering.